Assembly Biosciences, Inc. (ASMB) vs Contineum Therapeutics, Inc. (CTNM)

A side-by-side comparison of Assembly Biosciences, Inc. and Contineum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Assembly Biosciences, Inc. logo
ASMB
Assembly Biosciences, Inc.
$451M
$22.74HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Contineum Therapeutics, Inc. logo
CTNM
Contineum Therapeutics, Inc.
$479M
$12.72HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ASMB vs CTNM

growth of $100 · dividends reinvested · last 2y
ASMB +66.7% (+29.1%/yr)CTNM -17.4% (-9.1%/yr)ASMB compounded faster over this window
100200Start $10020252026$167$83
ASMB CTNM

ASMB vs CTNM: by the numbers

  • •CTNM is the larger company ($479M vs $451M market cap).

Metrics side by side

Valuation

MetricASMBCTNM
P/E ratio41.35N/A
P/S ratio6.02N/A
P/B ratio1.472.00

Profitability

MetricASMBCTNM
Gross margin99.82%0.00%
Operating margin-11.75%0.00%
Net margin-0.06%0.00%
ROE-0.01%-24.02%
ROIC-2.86%-27.22%

Growth (annualized)

MetricASMBCTNM
Revenue CAGR (5Y)-1.78%N/A
Total return CAGR (5Y)-10.66%N/A

Go deeper

Full ASMB analysisFull CTNM analysisInteractive comparison tool

Dig into the metrics

Assembly Biosciences P/E ratioAssembly Biosciences ROEContineum Therapeutics ROEAssembly Biosciences operating marginContineum Therapeutics operating marginAssembly Biosciences revenue growthContineum Therapeutics revenue growthAssembly Biosciences free cash flowContineum Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.